Form D · Biotechnology
CHRONIX BIOMEDICAL INC
San Jose, CA · CIK 0001129116
Offering snapshot reported Jul 18, 2017 · SEC filing
- Reported sold
- $3.31M Offering amount: $8M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Jun 30, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 18, 2017 | Initial | $3,306,954 | No comparison | 40 | SEC filing |
| May 18, 2017 | Initial | $1,471,041 | No comparison | 25 | SEC filing |
| Oct 31, 2016 | Initial | $5,012,802 | No comparison | 25 | SEC filing |
| Apr 9, 2014 | Amendment | $3,429,767 | $0vs Apr 8, 2014 | 26 | SEC filing |
| Apr 8, 2014 | Initial | $3,429,767 | No comparison | 26 | SEC filing |
| Oct 31, 2012 | Initial | $1,415,000 | No comparison | 7 | SEC filing |
| Mar 11, 2011 | Initial | $2,781,800 | No comparison | 11 | SEC filing |
| Sep 15, 2010 | Initial | $1,741,389 | No comparison | 14 | SEC filing |
| Nov 3, 2009 | Initial | $1,487,140 | No comparison | 14 | SEC filing |
| Feb 13, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 15, 2006 | Paper | Not reported | No comparison | Not reported | |
| May 15, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290970
Source: Form D, filed Jul 18, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Boeger Iii | Director |
| John Di Pietro | Executive |
| Paul Freiman | Director |
| Michael Jerstad | Director |
| Robert Leppo | Director |
| David Mac Kenzie | Director |
| William Mitchell | Director |
| Ekkehard Schuetz | Executive |
| Howard B Urnovitz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5941 Optical Court Suite 203 E
San Jose, CA, 95138
San Jose, CA, 95138